These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 24088073)

  • 21. Better documentation through standardized forms: what progress have we made since the 1800s?
    Cox L
    Allergy Asthma Proc; 2004; 25(6):407-22. PubMed ID: 15709452
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunological mechanisms of allergen-specific immunotherapy.
    Larché M; Akdis CA; Valenta R
    Nat Rev Immunol; 2006 Oct; 6(10):761-71. PubMed ID: 16998509
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunotherapy coming of age: notable advances during the first hundred years.
    Nelson HS
    Expert Rev Clin Immunol; 2017 May; 13(5):389-392. PubMed ID: 28443797
    [No Abstract]   [Full Text] [Related]  

  • 24. [Interests of recombinant allergens in the practice of allergy].
    Karoui O; Leimgruber A; Spertini F
    Rev Med Suisse; 2013 Jan; 9(368):22-7. PubMed ID: 23367699
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Management of polysensitized patient: from molecular diagnostics to biomolecular immunotherapy.
    Ciprandi G; Incorvaia C; Frati F;
    Expert Rev Clin Immunol; 2015; 11(9):973-6. PubMed ID: 26144241
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Allergy Immunotherapy: Are We Making Progress or Just Standing Still?
    Cox LS
    Immunol Allergy Clin North Am; 2020 Feb; 40(1):xiii-xiv. PubMed ID: 31761125
    [No Abstract]   [Full Text] [Related]  

  • 27. [Insect venom allergies : Update 2016 for otorhinolaryngologists].
    Klimek L; Dippold N; Sperl A
    HNO; 2016 Dec; 64(12):927-942. PubMed ID: 27787580
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Allergen immunotherapy, routes of administration and cytokine networks: an update.
    Cuppari C; Leonardi S; Manti S; Filippelli M; Alterio T; Spicuzza L; Rigoli L; Arrigo T; Lougaris V; Salpietro C
    Immunotherapy; 2014; 6(6):775-86. PubMed ID: 25186606
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Historical perspectives of allergy and immunology and allergen immunotherapy.
    Lockey RF
    Ann Allergy Asthma Immunol; 2014 Dec; 113(6):587-92. PubMed ID: 25454016
    [No Abstract]   [Full Text] [Related]  

  • 30. A review of allergy and allergen specific immunotherapy.
    Bidad K; Nicknam MH; Farid R
    Iran J Allergy Asthma Immunol; 2011 Mar; 10(1):1-9. PubMed ID: 21358009
    [TBL] [Abstract][Full Text] [Related]  

  • 31. New advances in allergy immunotherapy.
    Reisacher WR; Schwanke T
    Curr Opin Otolaryngol Head Neck Surg; 2016 Jun; 24(3):231-7. PubMed ID: 26926847
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Allergen immunotherapy: an updated review of safety.
    James C; Bernstein DI
    Curr Opin Allergy Clin Immunol; 2017 Feb; 17(1):55-59. PubMed ID: 27906697
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Novel routes for allergen immunotherapy: safety, efficacy and mode of action.
    Moingeon P; Mascarell L
    Immunotherapy; 2012 Feb; 4(2):201-12. PubMed ID: 22339462
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Role of allergen-specific immunotherapy (desensitization) for the treatment of allergies in Germany. Current situation].
    Kleine-Tebbe J; Ackermann-Simon J; Hanf G
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2012 Mar; 55(3):343-50. PubMed ID: 22373847
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Allergen immunotherapy (AIT) for the multiple-pollen sensitive patient.
    Nelson HS
    Expert Rev Clin Pharmacol; 2016 Nov; 9(11):1443-1451. PubMed ID: 27687128
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Does allergen immunotherapy alter the natural course of allergic disorders?
    Yang X
    Drugs; 2001; 61(3):365-74. PubMed ID: 11293647
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sublingual immunotherapy with venom for patients with Hymenoptera venom allergy.
    Patriarca G; Nucera E; Roncallo C; Aruanno A; Lombardo C; Decinti M; Pascolini L; Milani M; Buonomo A; Schiavino D
    J Allergy Clin Immunol; 2009 Aug; 124(2):385; author reply 385-6. PubMed ID: 19482349
    [No Abstract]   [Full Text] [Related]  

  • 38. The evolution of allergen and non-specific immunotherapy: past achievements, current applications and future outlook.
    Pajno GB; Nadeau KC; Passalacqua G; Caminiti L; Hobson B; Jay DC; Arasi S; Chiera F; Salzano G
    Expert Rev Clin Immunol; 2015 Jan; 11(1):141-54. PubMed ID: 25454510
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Honeybee venom immunotherapy: certainties and pitfalls.
    Bilò MB; Antonicelli L; Bonifazi F
    Immunotherapy; 2012 Nov; 4(11):1153-66. PubMed ID: 23194365
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Immunological mechanisms of allergen-specific immunotherapy].
    Allam JP; Novak N
    Hautarzt; 2017 Apr; 68(4):265-270. PubMed ID: 28299382
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.